Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

[1]  L. Liotta,et al.  Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[2]  B Angus,et al.  Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. , 1991, Journal of the National Cancer Institute.

[3]  C. Bucana,et al.  Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. , 1990, Journal of the National Cancer Institute.

[4]  T. Katada,et al.  Conversion of GDP into GTP by nucleoside diphosphate kinase on the GTP-binding proteins. , 1990, The Journal of biological chemistry.

[5]  L. Liotta,et al.  A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase , 1990, Cell.

[6]  Frank McCormick,et al.  The GTPase superfamily: a conserved switch for diverse cell functions , 1990, Nature.

[7]  L. Liotta,et al.  Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. , 1990, Cancer research.

[8]  K. Watanabe,et al.  Isolation and characterization of a cDNA clone encoding rat nucleoside diphosphate kinase. , 1990, The Journal of biological chemistry.

[9]  L. Liotta,et al.  Cloning and characterization of human tumor cell interstitial collagenase. , 1990, Cancer research.

[10]  L. Liotta,et al.  Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. , 1990, The Journal of biological chemistry.

[11]  L. Orci,et al.  Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene , 1990, Cell.

[12]  L. Orci,et al.  Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro , 1990, The Journal of cell biology.

[13]  O. Bârzu,et al.  Dictyostelium Nucleoside Diphospate Kinase Highly Homologous to Nm23 and Awd Proteins Involved in Mammalian Tumor Metastasis and Drosphila Development , 1990 .

[14]  L. Liotta,et al.  Clues to the function of Nm23 and Awd proteins in development, signal transduction, and tumor metastasis provided by studies of Dictyostelium discoideum. , 1990, Journal of the National Cancer Institute.

[15]  J. P. Thompson,et al.  Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. , 1990, The Journal of biological chemistry.

[16]  L. Liotta,et al.  Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. , 1990, Cancer research.

[17]  H. Birkedal‐Hansen,et al.  The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G M Clark,et al.  How to use prognostic factors in axillary node-negative breast cancer patients. , 1990, Journal of the National Cancer Institute.

[19]  B. Vallee,et al.  Zinc coordination, function, and structure of zinc enzymes and other proteins. , 1990, Biochemistry.

[20]  M A Moses,et al.  Identification of an inhibitor of neovascularization from cartilage. , 1990, Science.

[21]  Y. DeClerck,et al.  Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. , 1990, Journal of the National Cancer Institute.

[22]  J. Schittny,et al.  Molecular architecture of basement membranes , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  L. Matrisian,et al.  Stromelysin/transin and tumor progression. , 1990, Seminars in cancer biology.

[24]  L. Liotta,et al.  Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells , 1990, The Journal of cell biology.

[25]  T. Boone,et al.  cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Liotta,et al.  Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. , 1990, The American journal of pathology.

[27]  S. Inouye,et al.  Nucleoside diphosphate kinase from Myxococcus xanthus. I. Cloning and sequencing of the gene. , 1990, The Journal of biological chemistry.

[28]  W. McGuire,et al.  Cathepsin D and prognosis in breast cancer. , 1990, The New England journal of medicine.

[29]  L. Liotta,et al.  Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development , 1989, Nature.

[30]  A. Eisen,et al.  Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Liotta,et al.  Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. , 1989, The Journal of biological chemistry.

[32]  A. Eisen,et al.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.

[33]  H. Lu,et al.  Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. , 1989, The Journal of biological chemistry.

[34]  L. Liotta,et al.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. , 1989, Cancer research.

[35]  L. Liotta,et al.  Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. , 1989, Biochemistry.

[36]  C. Harris,et al.  Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. , 1989, Cancer research.

[37]  E. Gherardi,et al.  Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[39]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[40]  R. Miskin,et al.  Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells , 1989, Molecular and cellular biology.

[41]  C. Harris,et al.  Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line. , 1989, Journal of the National Cancer Institute.

[42]  M. Hendrix,et al.  Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. , 1989, Cancer research.

[43]  A. Eisen,et al.  Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Waterhouse,et al.  Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. , 1989, Science.

[45]  D. Rifkin,et al.  In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases , 1989, The Journal of cell biology.

[46]  L. Liotta,et al.  The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. , 1989, The Journal of biological chemistry.

[47]  D. Belin,et al.  Characterization of the cellular binding site for the urokinase-type plasminogen activator. , 1989, The Journal of biological chemistry.

[48]  L. Matrisian,et al.  Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. , 1988, Science.

[49]  M. Stearns,et al.  Blocking of collagenase secretion by estramustine during in vitro tumor cell invasion. , 1988, Cancer research.

[50]  R. Schultz,et al.  Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. , 1988, Cancer research.

[51]  J. Biggs,et al.  Molecular consequences of awdb3, a cell-autonomous lethal mutation of Drosophila induced by hybrid dysgenesis. , 1988, Developmental biology.

[52]  Y. Iwamoto,et al.  Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. , 1988, Cancer research.

[53]  A. Chambers,et al.  Clonal heterogeneity, experimental metastatic ability, and p21 expression in H-ras-transformed NIH 3T3 cells. , 1988, Journal of the National Cancer Institute.

[54]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[55]  V. Rotter,et al.  p53 increases experimental metastatic capacity of murine carcinoma cells , 1988, Molecular and cellular biology.

[56]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[57]  N. Shimada,et al.  Membrane-associated nucleoside diphosphate kinase from rat liver. Purification, characterization, and comparison with cytosolic enzyme. , 1988, The Journal of biological chemistry.

[58]  G. Peters,et al.  Amplification of the int-2 gene in primary human breast tumors. , 1988, Oncogene research.

[59]  E. Levin,et al.  Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells , 1987, The Journal of cell biology.

[60]  M. Gottesman,et al.  The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L. , 1987, The Biochemical journal.

[61]  K. Yanagihara,et al.  Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. , 1987, Science.

[62]  A. Eisen,et al.  Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[63]  L. Liotta,et al.  Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration , 1987, Nature.

[64]  G. Nicolson,et al.  Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. , 1987, Cancer research.

[65]  D. Belin,et al.  Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. , 1987, Cancer research.

[66]  L. Liotta,et al.  Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. , 1987, Cancer research.

[67]  G. Nicolson,et al.  Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. , 1987, Cancer research.

[68]  Richard O. Hynes,et al.  Integrins: A family of cell surface receptors , 1987, Cell.

[69]  D. Rifkin,et al.  Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.

[70]  M. Humphries,et al.  A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. , 1986, Science.

[71]  L. Liotta,et al.  Tumor cell autocrine motility factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[72]  L. Liotta,et al.  Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. , 1986, Science.

[73]  R. Thompson,et al.  Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Z. Werb,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.

[75]  L. Liotta,et al.  Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. , 1985, The American journal of pathology.

[76]  L. Liotta,et al.  Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. , 1985, Journal of the National Cancer Institute.

[77]  L. Liotta,et al.  NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice , 1985, Molecular and cellular biology.

[78]  J. Nickerson,et al.  The microtubule-associated nucleoside diphosphate kinase. , 1984, The Journal of biological chemistry.

[79]  K. Tryggvason,et al.  Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. , 1984, The Journal of biological chemistry.

[80]  L. Ossowski,et al.  Antibodies to plasminogen activator inhibit human tumor metastasis , 1983, Cell.

[81]  G. S. Johnson,et al.  Increased membrane-associated nucleoside diphosphate kinase activity as a possible basis for enhanced guanine nucleotide-dependent adenylate cyclase activity induced by picolinic acid treatment of simian virus 40-transformed normal rat kidney cells. , 1983, The Journal of biological chemistry.

[82]  G P Siegal,et al.  Loss of basement membrane components by invasive tumors but not by their benign counterparts. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[83]  L. Liotta,et al.  Basement membrane collagen: degradation by migrating endothelial cells. , 1983, Science.

[84]  S. R. Clark,et al.  Cell fusion segregates progressive growth from metastasis. , 1983, British Journal of Cancer.

[85]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[86]  A. Poole,et al.  A cysteine proteinase secreted from human breast tumours is immunologically related to cathepsin B. , 1982, The Biochemical journal.

[87]  L. Liotta,et al.  Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. , 1982, Journal of the National Cancer Institute.

[88]  I. Fidler,et al.  Biological diversity in metastatic neoplasms: origins and implications. , 1982, Science.

[89]  J. Reynolds,et al.  An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. , 1981, The Biochemical journal.

[90]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[91]  J. Richie,et al.  Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. , 1980, Cancer research.

[92]  L. Liotta,et al.  Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[93]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[94]  L. Liotta,et al.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.

[95]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[96]  W. Cliff.  Observations on healing tissue: A combined light and electron microscopic investigation , 1963, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.

[97]  L. Liotta,et al.  Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. , 1991, Cancer research.

[98]  R. Kerbel.  Growth dominance of the metastatic cancer cell: cellular and molecular aspects. , 1990, Advances in cancer research.

[99]  L. Wuestehube,et al.  The Dictyostelium Discoideum Plasma Membrane: A Model System for the Study of Actin-Membrane Interactions , 1990 .

[100]  D. Spandidos,et al.  The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review). , 1990, Anticancer research.

[101]  J. Wright,et al.  Oncogenes and metastatic progression. , 1989, Invasion & metastasis.

[102]  T. Slaga,et al.  Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression , 1988, Molecular carcinogenesis.

[103]  V. Schirrmacher.  Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. , 1985, Advances in cancer research.

[104]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[105]  L. Liotta,et al.  Protein synthesis but not DNA synthesis is required for tumor cell invasion in vitro. , 1984, Invasion & metastasis.

[106]  R. Parks,et al.  9 Nucleoside Diphosphokinases , 1973 .